N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline

C102H148N14O5 — CID 161068813

IUPACN-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline
SMILESCCC(CC)Nc1cc(-c2nc(C)no2)ccc1CC1CCCCC1.COc1cnc(CC2CCCCC2)c(NC2CCCCC2)c1.Cc1coc(-c2cnc(CC3CCCCC3)c(NC3CCCCC3)c2)n1.Cc1noc(-c2ccc(CC3CCCCC3)c(NC(C)C)c2)n1.Cc1noc(-c2ccc(CC3CCCCC3)c(NC3CCCC3)c2)n1
InChIInChI=1S/C22H31N3O.C21H29N3O.C21H31N3O.C19H27N3O.C19H30N2O/c1-16-15-26-22(24-16)18-13-21(25-19-10-6-3-7-11-19)20(23-14-18)12-17-8-4-2-5-9-17;1-15-22-21(25-24-15)18-12-11-17(13-16-7-3-2-4-8-16)20(14-18)23-19-9-5-6-10-19;1-4-19(5-2)23-20-14-18(21-22-15(3)24-25-21)12-11-17(20)13-16-9-7-6-8-10-16;1-13(2)20-18-12-17(19-21-14(3)22-23-19)10-9-16(18)11-15-7-5-4-6-8-15;1-22-17-13-19(21-16-10-6-3-7-11-16)18(20-14-17)12-15-8-4-2-5-9-15/h13-15,17,19,25H,2-12H2,1H3;11-12,14,16,19,23H,2-10,13H2,1H3;11-12,14,16,19,23H,4-10,13H2,1-3H3;9-10,12-13,15,20H,4-8,11H2,1-3H3;13-16,21H,2-12H2,1H3
InChIKeyUEJRJIQLZGKPFN-UHFFFAOYSA-N
MW1650.40 g/mol
LogP27.15
Rot. Bonds27

About N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline

N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline (PubChem CID 161068813) has the molecular formula C102H148N14O5 and a molecular weight of 1650.40 g/mol. Its IUPAC name is N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline.

Molecular Properties

Compound NameN-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline
PubChem CID161068813
Molecular FormulaC102H148N14O5
Molecular Weight1650.40 g/mol
Exact Mass1649.18
IUPAC NameN-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline
SMILESCCC(CC)Nc1cc(-c2nc(C)no2)ccc1CC1CCCCC1.COc1cnc(CC2CCCCC2)c(NC2CCCCC2)c1.Cc1coc(-c2cnc(CC3CCCCC3)c(NC3CCCCC3)c2)n1.Cc1noc(-c2ccc(CC3CCCCC3)c(NC(C)C)c2)n1.Cc1noc(-c2ccc(CC3CCCCC3)c(NC3CCCC3)c2)n1
InChIInChI=1S/C22H31N3O.C21H29N3O.C21H31N3O.C19H27N3O.C19H30N2O/c1-16-15-26-22(24-16)18-13-21(25-19-10-6-3-7-11-19)20(23-14-18)12-17-8-4-2-5-9-17;1-15-22-21(25-24-15)18-12-11-17(13-16-7-3-2-4-8-16)20(14-18)23-19-9-5-6-10-19;1-4-19(5-2)23-20-14-18(21-22-15(3)24-25-21)12-11-17(20)13-16-9-7-6-8-10-16;1-13(2)20-18-12-17(19-21-14(3)22-23-19)10-9-16(18)11-15-7-5-4-6-8-15;1-22-17-13-19(21-16-10-6-3-7-11-16)18(20-14-17)12-15-8-4-2-5-9-15/h13-15,17,19,25H,2-12H2,1H3;11-12,14,16,19,23H,2-10,13H2,1H3;11-12,14,16,19,23H,4-10,13H2,1-3H3;9-10,12-13,15,20H,4-8,11H2,1-3H3;13-16,21H,2-12H2,1H3
InChIKeyUEJRJIQLZGKPFN-UHFFFAOYSA-N
XLogP27.15
TPSA237.95 Ų
H-Bond Donors5
H-Bond Acceptors19
Rotatable Bonds27
Heavy Atoms121
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001650.40
LogP ≤ 527.15
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1019

Analyze N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-(5-Methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid;2-methyl-2-(2-phenyl-1,3-oxazol-4-yl)propan-1-amine;4-methyl-4-(2-phenyl-1,3-oxazol-4-yl)-1-[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-3-pyridinyl]pentan-1-one
CID 157244251
2-[6-benzo[h]quinolin-2-yl-7-(furan-2-yl)-5-(1H-imidazol-2-yl)-4-isoquinolin-1-yl-2-(1,2-oxazol-3-yl)-1H-indol-3-yl]-1,3-oxazole
CID 141106718
2-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]propan-1-amine;N-[2-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]propyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid
CID 157061987
cumene;bis(5-cyclobutyl-3-methyl-1,2,4-oxadiazole);bis(5-cyclohexyl-3-methyl-1,2,4-oxadiazole);5-(2,3-dihydro-1H-inden-5-yl)-3-methyl-1,2,4-oxadiazole;methane;3-(3-methyl-1,2,4-oxadiazol-5-yl)cyclohexan-1-one;bis(2-methyl-5-phenyl-1,3,4-oxadiazole);3-methyl-5-phenyl-1,2,4-oxadiazole;5-methyl-3-phenyl-1,2,4-oxadiazole;3-methyl-5-phenyl-1,2-oxazole;4-methyl-2-phenyl-1,3-oxazole;1-methyl-4-phenylpiperidine;4-methyl-1-phenyltriazole;3-methyl-5-pyridin-3-yl-1,2,4-oxadiazole;3-methyl-5-pyrrolidin-3-yl-1,2,4-oxadiazole;1-phenylethanone;propylbenzene
CID 157091264
N-[3-[(2-hydroxy-4-methylphenyl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(3-hydroxy-4-methylphenyl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-(1H-indol-3-ylmethylamino)propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(5-methoxy-3-pyridinyl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(4-methylfuran-2-yl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(2-methyl-1,3-oxazol-5-yl)methylamino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;N-[3-[(5-methyl-2-pyridinyl)amino]propyl]-5-phenyl-1,2-oxazole-3-carboxamide;5-phenyl-N-[3-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylamino)propyl]-1,2-oxazole-3-carboxamide
CID 157267222
5-(1,3-Benzoxazol-2-yl)-2-(oxan-4-ylmethyl)aniline;2-[1-(oxan-4-yl)-2-pyridin-3-ylbenzimidazol-5-yl]-1,3-benzoxazole
CID 157775477
N,N-dimethyl-3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)aniline;5-[3-(furan-2-yl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;N-methyl-3-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)aniline;5-[3-(1,3-oxazol-4-yl)phenyl]-3-pyridin-4-yl-1,2,4-oxadiazole;3-pyridin-4-yl-5-(3-pyrrolidin-1-ylphenyl)-1,2,4-oxadiazole;3-pyridin-4-yl-5-(4-pyrrolidin-1-ylphenyl)-1,2,4-oxadiazole
CID 157843586
4-[4-(2-aminoethyl)-1,3-oxazol-2-yl]benzonitrile;N-[2-[2-(4-cyanophenyl)-1,3-oxazol-4-yl]ethyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid
CID 157887807
1-(3-amino-4-deca-3,5-diynylphenyl)-4-piperidin-1-ylbutan-1-one;tert-butyl 5-(cyclohexylamino)-6-(cyclohexylmethyl)pyridine-3-carboxylate;N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)-N-propan-2-ylaniline
CID 157941843
Cumene;bis(5-cyclobutyl-3-methyl-1,2,4-oxadiazole);bis(5-cyclohexyl-3-methyl-1,2,4-oxadiazole);bis(2-methyl-5-phenyl-1,3,4-oxadiazole);3-methyl-5-phenyl-1,2,4-oxadiazole;5-methyl-3-phenyl-1,2,4-oxadiazole;3-methyl-5-phenyl-1,2-oxazole;4-methyl-2-phenyl-1,3-oxazole;1-methyl-4-phenylpiperidine;3-methyl-5-pyridin-3-yl-1,2,4-oxadiazole;3-methyl-5-pyrrolidin-3-yl-1,2,4-oxadiazole
CID 158016347
N-benzyl-2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-(pyridin-4-ylmethyl)aniline;N-cyclopentyl-2-(cyclopentylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclopentylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline;ethyl 5-amino-6-(cyclohexylmethyl)pyridine-3-carboxylate
CID 158051649
2-[2-(3-fluorophenyl)-1,3-oxazol-4-yl]ethanamine;N-[2-[2-(3-fluorophenyl)-1,3-oxazol-4-yl]ethyl]-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxamide;5-(5-methyl-1,2,4-oxadiazol-3-yl)pyridine-3-carboxylic acid
CID 158166388

Frequently Asked Questions

What is the IUPAC name of N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline?
The IUPAC name of N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline (CID 161068813) is N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline.
What is the SMILES notation for N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline?
The canonical SMILES for N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline is CCC(CC)Nc1cc(-c2nc(C)no2)ccc1CC1CCCCC1.COc1cnc(CC2CCCCC2)c(NC2CCCCC2)c1.Cc1coc(-c2cnc(CC3CCCCC3)c(NC3CCCCC3)c2)n1.Cc1noc(-c2ccc(CC3CCCCC3)c(NC(C)C)c2)n1.Cc1noc(-c2ccc(CC3CCCCC3)c(NC3CCCC3)c2)n1.
What is the InChIKey of N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline?
The InChIKey is UEJRJIQLZGKPFN-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H31N3O.C21H29N3O.C21H31N3O.C19H27N3O.C19H30N2O/c1-16-15-26-22(24-16)18-13-21(25-19-10-6-3-7-11-19)20(23-14-18)12-17-8-4-2-5-9-17;1-15-22-21(25-24-15)18-12-11-17(13-16-7-3-2-4-8-16)20(14-18)23-19-9-5-6-10-19;1-4-19(5-2)23-20-14-18(21-22-15(3)24-25-21)12-11-17(20)13-16-9-7-6-8-10-16;1-13(2)20-18-12-17(19-21-14(3)22-23-19)10-9-16(18)11-15-7-5-4-6-8-15;1-22-17-13-19(21-16-10-6-3-7-11-16)18(20-14-17)12-15-8-4-2-5-9-15/h13-15,17,19,25H,2-12H2,1H3;11-12,14,16,19,23H,2-10,13H2,1H3;11-12,14,16,19,23H,4-10,13H2,1-3H3;9-10,12-13,15,20H,4-8,11H2,1-3H3;13-16,21H,2-12H2,1H3.
What are the key properties of N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline?
N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline has a molecular weight of 1650.40 g/mol, XLogP of 27.15, 27 rotatable bonds, 5 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclohexyl-2-(cyclohexylmethyl)-5-methoxypyridin-3-amine;N-cyclohexyl-2-(cyclohexylmethyl)-5-(4-methyl-1,3-oxazol-2-yl)pyridin-3-amine;2-(cyclohexylmethyl)-N-cyclopentyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)aniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-pentan-3-ylaniline;2-(cyclohexylmethyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-N-propan-2-ylaniline is sourced from PubChem (CID 161068813), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).